ACLY and hepatocellular carcinoma: In a mouse hepatoma model, metformin decreased de novo fatty acid synthesis by reducing, transcriptionally, the expression of acetyl CoA carboxylase, fatty acid synthase (FASN) and ATP citrate lyase (ACLY) [56].